News Alerts: - Wyeth to develop drug for side effects
Wyeth to develop drug for side effects
bizjournals.com via Yahoo! Finance - Dec 23 7:07 AM
Wyeth Pharmaceuticals and Progenics Pharmaceuticals Inc. entered into an exclusive, worldwide agreement Friday to jointly develop and commercialize methylnaltrexone, also known as MNTX, for the treatment of side effects, including constipation and post-operative bowel dysfunction, associated with certain pain medicines.Save to My Web
Stopping iron solves embarassing problem
Hampton Roads Daily Press - Dec 28 4:24 AM
Q: I had a problem with flatulence so embarrassing I couldn’t discuss it with anyone but my husband. The main problem was a horrible smell.Save to My Web
Worthwhile Motherly Advice
The Gilroy Dispatch - Dec 27 10:31 AM
Shocking as this seems, the other day, in the middle of the afternoon, a fantasy of mine came true. Oh, I don’t mean the passionate running-away-to-live-with-Jude-Law-in-a-cottage-by-the-sea type fantasy. Although there’s nothing wrong with that, mind you.Save to My Web
New Clinical Trial in Children with Autism Begins Enrollment
[Press Release] PR Newswire via Yahoo! Finance - Dec 22 5:00 AM
Autism Spectrum Treatment and Research Center has begun accepting candidates for a research study to evaluate an investigational medication for persistent gastrointestinal dysfunction in autistic children.Save to My Web
